| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/15/2002 | WO2002018554A3 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
| 08/15/2002 | WO2002013763A3 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 08/15/2002 | WO2002008455A3 Method for unraveling double-stranded nucleic acids located in a solution into single-stranded nucleic acids |
| 08/15/2002 | WO2002008261A3 Bstp-trans protein and related reagents and methods of use thereof |
| 08/15/2002 | WO2002006828A3 Hemoglobin sensor |
| 08/15/2002 | WO2002006303A3 Dna vaccines encoding hiv accessory proteins |
| 08/15/2002 | WO2002002740A3 Methods and compositions for determining gene function |
| 08/15/2002 | WO2002000897A3 Novel chimeric promoters |
| 08/15/2002 | WO2001092559A3 Screening system for antibiotics |
| 08/15/2002 | WO2001092303A3 Human ion channels |
| 08/15/2002 | WO2001090308A3 Method of determining thiopurine methyltransferase activity |
| 08/15/2002 | WO2001088177A8 Stain solution, which is devoid of phenol, for bacteria |
| 08/15/2002 | WO2001085995A9 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene |
| 08/15/2002 | WO2001083819A3 Methods for designing exogenous regulatory molecules |
| 08/15/2002 | WO2001079527A3 Sexual fidelity and sex crime verification |
| 08/15/2002 | WO2001071034A3 Methods and apparatus for parallel magnetic biological analysis and manipulation |
| 08/15/2002 | WO2001066753A3 Human genes and gene expression products |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001061039A3 5-hydroxytryptamine transporter gene polymorphisms |
| 08/15/2002 | WO2001059157A3 Process for the enumeration and identification of microorganisms |
| 08/15/2002 | WO2001034302A9 Biochannel assay for hybridization with biomaterial |
| 08/15/2002 | WO2001032933A9 Assay method for determining product r's effect on induction of ifn-gamma in cultured cells |
| 08/15/2002 | WO2001032927A3 Tissue specific genes of diagnostic import |
| 08/15/2002 | WO2001032877A9 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 08/15/2002 | WO2001032802A9 Method and apparatus for predicting male infertility |
| 08/15/2002 | WO2001019856A3 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 08/15/2002 | WO2001019482A9 Method for sequencing reaction cleanup by constant pressure differential ultrafiltration |
| 08/15/2002 | WO1999064067A9 Vaccine |
| 08/15/2002 | US20020111746 Systems and computer software products for gene expression analysis |
| 08/15/2002 | US20020111473 Novel g protein coupled receptor |
| 08/15/2002 | US20020111472 T1-r ligand iii |
| 08/15/2002 | US20020111470 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 08/15/2002 | US20020111467 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/15/2002 | US20020111463 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 08/15/2002 | US20020111325 VEGI, an inhibitor of angiogenesis and tumor growth |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020111293 Modulator of tyrosine kinase receptors |
| 08/15/2002 | US20020111290 Calibration of chemokine or receptor expression; medical diagnosis |
| 08/15/2002 | US20020110932 Apparatus for use in humans diagnostics and drug development |
| 08/15/2002 | US20020110928 Device for use in the analysis and coding of animal and plants tissues |
| 08/15/2002 | US20020110904 High throughput apparatus for use in quantitative and qualitative analysis of biopolymes in solution |
| 08/15/2002 | US20020110903 Blocking of device for detecting biochemically active molecules |
| 08/15/2002 | US20020110900 Low volume chemical and biochemical reaction system |
| 08/15/2002 | US20020110895 Nucleotide sequences coding enzymatic polypeptide for use in treatment of thrombosis and in the immune defects |
| 08/15/2002 | US20020110892 Human RNase H and compositions and uses thereof |
| 08/15/2002 | US20020110890 Expression vector for use in the monitoring of cyclic adenosine monophosphate concentration |
| 08/15/2002 | US20020110889 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110888 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/15/2002 | US20020110883 Novel motor proteins and methods for their use |
| 08/15/2002 | US20020110870 Therapeutic applications for CCR5 chemokine receptors |
| 08/15/2002 | US20020110862 Novel Siglec-like gene |
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110848 Monitoring cell preparations for preferential response substrates; obtain microtiter plates, fill with cells, incubate with substrate, monitor response to substrate |
| 08/15/2002 | US20020110847 Method for measuring a state variable |
| 08/15/2002 | US20020110846 Kit for use in the detection of biopolymers bound to solid support |
| 08/15/2002 | US20020110845 Method for the prediction of starch digestion |
| 08/15/2002 | US20020110844 Test strip for determining dialysate composition |
| 08/15/2002 | US20020110841 Regulation of cell growth by MUC1 |
| 08/15/2002 | US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators |
| 08/15/2002 | US20020110839 Micro-array evanescent wave fluorescence detection device |
| 08/15/2002 | US20020110837 Detecting modulators of nervous system activity; obtain cells, incubate with modulators, monitor adjustment in nervous system activity |
| 08/15/2002 | US20020110836 PD-L2 molecules: novel PD-1 ligands and uses therefor |
| 08/15/2002 | US20020110834 Fluorescent assay for proteolysis |
| 08/15/2002 | US20020110833 Methods to diagnose a required regulation of trophoblast invasion |
| 08/15/2002 | US20020110830 Monitoring vascular endothelial growth factor activity in a sample; obtain sample, incubate with preferential genetically engineered cells, detecting expression of the reporter element, expression indicates growth factor activity |
| 08/15/2002 | US20020110829 Method for isolating nucleic acids from a liquid sample containing nucleic acids |
| 08/15/2002 | US20020110828 Methods and compositions for microarray control |
| 08/15/2002 | US20020110826 Oligonucleotide probe for use in hybridization analysis |
| 08/15/2002 | US20020110824 Screening for modulators of dermatitis; obtain tissue sample, incubate with modulator, monitor expression of preferential cytokine, presence of cytokine indicates dermatitis |
| 08/15/2002 | US20020110823 Screening human to determine proability of side effects to surgery; obtain tissue sample, extract nucleotide sequences, determine expression pattern of preferential genes |
| 08/15/2002 | US20020110822 Classification of preferential dermatitus; obtain skin sample, recover nucleotide sequences, monitor expression pattern of cytokine, classify dermatitis |
| 08/15/2002 | US20020110821 Cancer gene determination and therapeutic screening using signature gene sets |
| 08/15/2002 | US20020110820 Classification of tumors; obtain tumor sample, monitor preferential gene expression pattern, compare to tumor control, classify tumor |
| 08/15/2002 | US20020110819 Method for analysis of oligonucleotide analogs |
| 08/15/2002 | US20020110818 Methods of analyzing polymers using ordered label strategies |
| 08/15/2002 | US20020110815 Nucleotide sequences which code polypeptide for use in the treatment of tumors |
| 08/15/2002 | US20020110814 Method and kit for the screening, the detection and/or the quantification of transcriptional factors |
| 08/15/2002 | US20020110812 Nucleic acid collection barrier method and apparatus |
| 08/15/2002 | US20020110810 Diagnosing helicobacter pylori infection; obtain infected cells, extract nuclelotide sequences, detect microorganismal nucleotide sequences, evaluate for microorganism infection |
| 08/15/2002 | US20020110807 Detection of liver tumors; quantitative analysis |
| 08/15/2002 | US20020110806 Detecting preferential biopolymer on solid support; generate solid support joined with bioploymer, incubate with bacteriophage, remove unbound phage, detecting replicated bound bacteriophage |
| 08/15/2002 | US20020110805 Peptide for use in the treatment of glomerulonephritis, psoriasis, leukemia, antherosclerosis, autoimmune diseases, inflammatory, arthritic, asthmatic, and fibrotic disorders |
| 08/15/2002 | US20020110800 Use of SHP-1 and SHP-2 to detect compounds involved in neuronal survival |
| 08/15/2002 | US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH) |
| 08/15/2002 | US20020110545 Adenovector pharmaceutical composition |
| 08/15/2002 | US20020110523 Determining whether an increase of compound on level of acute phase reactant or metabolic derivative has occurred since applying compound or to subject; increase in level of acute phase reactant indicates negative side effect |
| 08/15/2002 | US20020108908 A polymeric support, a dye attached to a fraction of the polymeric support to enable optical detection of polymeric support, and an affinity ligand other than dye attached to a fraction of polymeric support for capture of biomolecule |
| 08/15/2002 | US20020108857 Robotic-equipped modular stations; for amplification of genetic material for example; high-throughput and fully automated processing of genetic materials |
| 08/15/2002 | CA2796391A1 Myeloperoxidase, a risk indicator for cardiovascular disease |
| 08/15/2002 | CA2440978A1 Myeloperoxidase, a risk indicator for cardiovascular disease |
| 08/15/2002 | CA2438018A1 Markers of unstable atherosclerotic plaques |
| 08/15/2002 | CA2437750A1 Prc17: an amplified cancer gene |
| 08/15/2002 | CA2437727A1 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 08/15/2002 | CA2437717A1 G-protein coupled receptors |
| 08/15/2002 | CA2437665A1 Gap junction permeability assay |
| 08/15/2002 | CA2437648A1 Multipotent o-2a progenitors from the neurohypophysis |
| 08/15/2002 | CA2437577A1 Human sphingosine-1-phosphate phosphatase |
| 08/15/2002 | CA2437573A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437572A1 Method for the production of plant seed with modified fibre content and modified seed coat |